LGVN
Longeveron Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.81
+3.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 15.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.09x
- Price / sales
- 18.29x
- Price / cash flow
- -1.07x
Enterprise value
- Enterprise value
- $12.2M
- EV / sales
- 10.29x
- EV / EBITDA
- -0.53x
- EV / EBIT
- -0.52x
- Market cap
- $21.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026